• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆置换次数较少以及肾小球滤过率下降与重症肌无力患者的第二次复发相关。

Lower number of plasma exchange sessions and glomerular filtration rate decline are associated with second relapses in patients with myasthenia gravis.

作者信息

Premuzic Vedran, Bilic Ervina, Sepec Branimir Ivan, Hancevic Mirea, Bilic Hrvoje, Sitas Barbara, Sprljan Alfirev Rujana, Jelakovic Bojan

机构信息

Department of Nephrology, Hypertension, Dialysis and Transplantation.

Department of Neurology, University Hospital Centre Zagreb, Zagreb, Croatia.

出版信息

Medicine (Baltimore). 2020 Feb;99(6):e19100. doi: 10.1097/MD.0000000000019100.

DOI:10.1097/MD.0000000000019100
PMID:32028436
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7015643/
Abstract

The aims were to determine the impact of dysphagia and glomerular filtration rate (GFR) in the prediction of myasthenia relapse and analyse whether different number of plasma exchange sessions could prolong the time before future relapse.This was a retrospective, longitudinal follow-up study with 60 enrolled patients. The patients were followed-up for a total of 50 months.Patients without relapses had significantly higher GFR and higher number of plasma exchange sessions when compared to patients with relapses. Mean time before next myasthenia relapse was significantly longer in patients with GFR ≥ 60 mL/min. Time before next and number of following myasthenia relapses were significantly higher in patients with symptoms of dysphagia.Decline in GFR levels is strongly associated with the presence of dysphagia and independently impacts the onset of myasthenia relapses. Timely initiation of plasmapheresis therapy and adequate hydration of patients with prolonged dysphagia should be one of the treatment goals for clinicians treating this disease.

摘要

本研究旨在确定吞咽困难和肾小球滤过率(GFR)对重症肌无力复发预测的影响,并分析不同次数的血浆置换疗程是否能延长未来复发前的时间。这是一项对60例入组患者进行的回顾性纵向随访研究。患者总共随访了50个月。与复发患者相比,未复发患者的GFR显著更高,血浆置换疗程次数更多。GFR≥60 mL/min的患者下次重症肌无力复发前的平均时间显著更长。有吞咽困难症状的患者下次复发前的时间和后续复发次数显著更高。GFR水平下降与吞咽困难的存在密切相关,并独立影响重症肌无力复发的发生。及时开始血浆置换治疗以及对吞咽困难持续时间较长的患者进行充分补液应是治疗该疾病的临床医生的治疗目标之一。

相似文献

1
Lower number of plasma exchange sessions and glomerular filtration rate decline are associated with second relapses in patients with myasthenia gravis.血浆置换次数较少以及肾小球滤过率下降与重症肌无力患者的第二次复发相关。
Medicine (Baltimore). 2020 Feb;99(6):e19100. doi: 10.1097/MD.0000000000019100.
2
Myasthenia gravis: descriptive analysis of life-threatening events in a recent nationwide registry.重症肌无力:最近全国性登记研究中危及生命事件的描述性分析。
Eur J Neurol. 2015 Jul;22(7):1056-61. doi: 10.1111/ene.12703. Epub 2015 Apr 6.
3
[Late onset forms of myasthenia gravis. Comparison with early-onset myasthenia gravis].[重症肌无力的迟发型。与早发型重症肌无力的比较]
Rev Neurol (Paris). 2006 Oct;162(10):990-6. doi: 10.1016/s0035-3787(06)75109-8.
4
Plasma exchange for myasthenia gravis.用于重症肌无力的血浆置换
Cochrane Database Syst Rev. 2002;2002(4):CD002275. doi: 10.1002/14651858.CD002275.
5
Anti-MuSK Antibody-positive Myasthenia Gravis Successfully Treated with Outpatient Periodic Weekly Blood Purification Therapy.门诊定期每周血液净化疗法成功治疗抗肌肉特异性酪氨酸激酶抗体阳性重症肌无力
Intern Med. 2018 May 15;57(10):1455-1458. doi: 10.2169/internalmedicine.9466-17. Epub 2018 Jan 11.
6
Clinical and electrophysiological evaluation of dysphagia in myasthenia gravis.重症肌无力吞咽困难的临床与电生理评估
J Neurol Neurosurg Psychiatry. 1998 Dec;65(6):848-56. doi: 10.1136/jnnp.65.6.848.
7
Myasthenia gravis presenting as dysphagia: clinical considerations.以吞咽困难为表现的重症肌无力:临床考量
Am J Gastroenterol. 1994 Jul;89(7):1083-5.
8
Less is more: treatment of aggravating behaviour in myasthenia gravis patients with dysphagia.少即是多:重症肌无力吞咽困难患者激越行为的治疗
Eur J Neurol. 2002 Nov;9(6):688-9. doi: 10.1046/j.1468-1331.2002.00447_3.x.
9
Comparative study of clinical effects between plasma adsorption and double filtration plasmapheresis in patients with myasthenia gravis.血浆吸附与双重过滤血浆置换治疗重症肌无力的临床效果比较研究
Ther Apher. 1997 Nov;1(4):343-7. doi: 10.1111/j.1744-9987.1997.tb00052.x.
10
[Dysphagia and dysarthria: unusual presentation of Myasthenia Gravis].[吞咽困难与构音障碍:重症肌无力的不寻常表现]
Acta Med Port. 2007 Sep-Oct;20(5):463-6. Epub 2008 Jan 24.

引用本文的文献

1
Myasthenia Gravis: Novel Findings and Perspectives on Traditional to Regenerative Therapeutic Interventions.重症肌无力:从传统治疗到再生治疗干预的新发现与展望
Aging Dis. 2023 Aug 1;14(4):1070-1092. doi: 10.14336/AD.2022.1215.

本文引用的文献

1
Dysphagia in myasthenia gravis: the tip of the Iceberg.重症肌无力中的吞咽困难:冰山一角。
Acta Neurol Belg. 2018 Jun;118(2):259-266. doi: 10.1007/s13760-018-0884-1. Epub 2018 Feb 7.
2
Clinical outcome and predictive factors of postoperative myasthenic crisis in 173 thymomatous myasthenia gravis patients.173例胸腺瘤型重症肌无力患者术后肌无力危象的临床结局及预测因素
Int J Neurosci. 2018 Feb;128(2):103-109. doi: 10.1080/00207454.2017.1366905. Epub 2017 Oct 2.
3
Clinical predictors for the prognosis of myasthenia gravis.重症肌无力预后的临床预测因素
BMC Neurol. 2017 Apr 19;17(1):77. doi: 10.1186/s12883-017-0857-7.
4
Clinical and immunological predictors of prognosis for Japanese patients with thymoma-associated myasthenia gravis.胸腺瘤相关重症肌无力日本患者预后的临床和免疫学预测因子。
J Neuroimmunol. 2013 May 15;258(1-2):61-6. doi: 10.1016/j.jneuroim.2013.03.001. Epub 2013 Apr 3.
5
The CKD-EPI equation for estimating GFR from serum creatinine: real improvement or more of the same?用于根据血清肌酐估算肾小球滤过率(GFR)的慢性肾脏病流行病学合作(CKD-EPI)方程:是真正的改进还是换汤不换药?
Clin J Am Soc Nephrol. 2010 Jun;5(6):951-3. doi: 10.2215/CJN.03110410. Epub 2010 May 6.
6
Course and prognosis of myasthenia gravis: a systematic review.重症肌无力的病程和预后:系统评价。
Eur J Neurol. 2010 Jul;17(7):913-21. doi: 10.1111/j.1468-1331.2010.03017.x. Epub 2010 Apr 12.
7
[Prognostic factors related to recurrence after extended thymectomy in patients with myasthenia gravis].[重症肌无力患者扩大胸腺切除术后复发的相关预后因素]
Zhonghua Yi Xue Za Zhi. 2008 Jun 3;88(21):1446-9.
8
The effect of prednisone on the progression from ocular to generalized myasthenia gravis.泼尼松对眼肌型重症肌无力进展为全身型重症肌无力的影响。
J Neurol Sci. 2004 Feb 15;217(2):131-3. doi: 10.1016/j.jns.2003.08.017.
9
Development of generalized myasthenia gravis in patients with ocular myasthenia gravis.眼肌型重症肌无力患者发生全身型重症肌无力
Arch Neurol. 2003 Oct;60(10):1491-2. doi: 10.1001/archneur.60.10.1491-b.
10
Relapse of ocular symptoms after remission of myasthenia gravis--a comparison of relapsed and complete remission cases.重症肌无力缓解后眼部症状复发——复发与完全缓解病例的比较
Clin Neurol Neurosurg. 2003 Apr;105(2):75-7. doi: 10.1016/s0303-8467(02)00104-x.